https://www.newswire.ca/news-releases/medtronic-extravascular-icd-meets-global-pivotal-clinical-trial-s-safety-and-effectiveness-endpoints-840548088.html
/CNW/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced that its investigational EV ICD™ System – a first-of-its-kind...
Create an account or login to join the discussion